Keywords: Merck & Co, Impax Labs, Vytorin, Patent infringement, Patent cliff

Merck & Co sues Impax Labs over Vytorin patent infringement in USA, as firm faces “patent cliff”

Article | 24 August 2010

Print This

US pharma giant Merck & Co (MRK: NY) Friday sued Impax Laboratories (Nasdaq: IPXL) in the federal court in New ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in